THY1 and Alzheimer disease: Cell characterisation by flow cytometry revealed that late passage AD-MSCs under constant inflammation (IFNγ‐C) show a decreased expression of CD90 and CD105, canonical MSCs markers according to ISCT (Fig. 3D).